EXHIBIT 10.17 OPTION AGREEMENTOption Agreement • March 20th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Contract Type FiledMarch 20th, 2000 Company Industry Jurisdiction
andRights Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research
Contract Type FiledApril 5th, 2000 Company Industry
EXHIBIT 10.22 CONTRIBUTION AGREEMENTContribution Agreement • August 11th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
Contract Type FiledAugust 11th, 2000 Company Industry Jurisdiction
EXHIBIT 2 SHAREHOLDERS AGREEMENTShareholders Agreement • April 5th, 2001 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
Contract Type FiledApril 5th, 2001 Company Industry Jurisdiction
CONFORMED COPY AMENDED AND RESTATED 364-DAY CREDIT AGREEMENT364-Day Credit Agreement • May 15th, 2001 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
Contract Type FiledMay 15th, 2001 Company Industry Jurisdiction
DRAFT: FEBRUARY 14, 2000 ----- REORGANIZATION AGREEMENT Dated as of March 15, 2000 by and between BAXTER INTERNATIONAL INC.Reorganization Agreement • February 18th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Contract Type FiledFebruary 18th, 2000 Company Industry Jurisdiction
Edwards Lifesciences Corporation and Equiserve Trust Company, N.A. as Rights Agent Rights Agreement Dated as of March 31, 2000Rights Agreement • May 15th, 2003 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Delaware
Contract Type FiledMay 15th, 2003 Company Industry JurisdictionRIGHTS AGREEMENT, dated as of March 31, 2000 (the "Agreement"), between Edwards Lifesciences Corporation, a Delaware corporation (the "Company"), and Equiserve Trust Company, N.A., a federally chartered trust company (the "Rights Agent").
EXHIBIT 10.4 CHANGE-IN-CONTROL SEVERANCE AGREEMENT Edwards Lifesciences Corporation April 2000 CONTENTSChange-in-Control Severance Agreement • March 27th, 2001 • Edwards Lifesciences Corp • Services-commercial physical & biological research
Contract Type FiledMarch 27th, 2001 Company Industry
BY AND BETWEENTax Sharing Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Contract Type FiledApril 5th, 2000 Company Industry Jurisdiction
EXHIBIT 2.1 =================================================================== ============= AMENDED AND RESTATED ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 15th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
Contract Type FiledSeptember 15th, 2000 Company Industry Jurisdiction
EXHIBIT 10.18 JAPAN DISTRIBUTION AGREEMENT dated as of April 1, 2000Distribution Agreement • March 20th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Contract Type FiledMarch 20th, 2000 Company Industry Jurisdiction
Exhibit 10.5 Employment Agreement for Michael A. Mussallem Edwards Lifesciences Corporation March 2000 ContentsEmployment Agreement • March 15th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Delaware
Contract Type FiledMarch 15th, 2000 Company Industry Jurisdiction
CONFORMED COPY AMENDMENT NO. 2, dated as of March 29, 2001 (this "Amendment"), to the FIVE YEAR CREDIT AGREEMENT dated as of March 30, 2000 (as amended, the "Credit Agreement") among EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation (the...Five Year Credit Agreement • May 15th, 2001 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
Contract Type FiledMay 15th, 2001 Company Industry Jurisdiction
EXHIBIT 1 SECURITIES PURCHASE AGREEMENT by and between EDWARDS LIFESCIENCES CORPORATION, PLC SYSTEMS INC.Securities Purchase Agreement • April 5th, 2001 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
Contract Type FiledApril 5th, 2001 Company Industry Jurisdiction
EDWARDS LIFESCIENCES CORPORATION (a Delaware corporation) $600,000,000 4.300% Senior Notes due 2028 UNDERWRITING AGREEMENT Dated: June 6, 2018Underwriting Agreement • June 7th, 2018 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledJune 7th, 2018 Company Industry Jurisdiction
ARTICLE I DEFINITIONS -----------Tax Sharing Agreement • February 18th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Contract Type FiledFebruary 18th, 2000 Company Industry Jurisdiction
RELATING TOOption Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Contract Type FiledApril 5th, 2000 Company Industry Jurisdiction
EXHIBIT 10.18 JAPAN DISTRIBUTION AGREEMENT dated as of April 1, 2000 by and between BAXTER LIMITEDDistribution Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research • Illinois
Contract Type FiledApril 5th, 2000 Company Industry Jurisdiction
Exhibit 10.13 CONFIDENTIALITY AGREEMENT THIS AGREEMENT entered into by and between ________________ having an address at _____________ ("RECIPIENT") and Edwards Lifescience Corporation, a Delaware corporation, having an address at _____________,...Confidentiality Agreement • February 18th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research
Contract Type FiledFebruary 18th, 2000 Company Industry
Chief Executive Officer Change-in-Control Severance Agreement Edwards Lifesciences Corporation As Amended and Restated March 30, 2009Change-in-Control Severance Agreement • May 8th, 2009 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies
Contract Type FiledMay 8th, 2009 Company IndustryTHIS AMENDED AND RESTATED CHIEF EXECUTIVE OFFICER CHANGE-IN-CONTROL SEVERANCE AGREEMENT (the "Restated Agreement") is made, entered into, and is effective this 30th day of March, 2009 (hereinafter referred to as the "Effective Date"), by and between Edwards Lifesciences Corporation (the "Company"), a Delaware corporation, and Michael A. Mussallem (the "Executive").
FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • February 27th, 2012 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledFebruary 27th, 2012 Company Industry JurisdictionThis Indemnification Agreement, dated as of (this "Agreement"), is entered into by and between Edwards Lifesciences Corporation, a Delaware corporation (together with its subsidiaries, the "Company"), and (the "Indemnitee").
Exhibit 10.11 FORM OF EMPLOYMENT AGREEMENT (NOTE: BEFORE SIGNING, PROSPECTIVE EMPLOYEES SHOULD READ THE FOLLOWING AGREEMENT IN ITS ENTIRETY, MAKE CERTAIN THAT THEY UNDERSTAND IT, AND IF DESIRED, REVIEW IT WITH THEIR ATTORNEYS AND ADVISORS.) In...Employment Agreement • January 21st, 2000 • CVG Controlled Inc • Services-commercial physical & biological research • Illinois
Contract Type FiledJanuary 21st, 2000 Company Industry Jurisdiction
Separation Agreement Between Edwards Lifesciences Corporation and Stuart L. FosterSeparation Agreement • May 9th, 2008 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • California
Contract Type FiledMay 9th, 2008 Company Industry JurisdictionThis Agreement, (the "Agreement") is entered into by and between Edwards Lifesciences Corporation (together with its subsidiaries and affiliates, "Edwards") and Stuart L. Foster, Corporate Vice President, Critical Care and Vascular, of Edwards ("Executive").
Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program Global Restricted Stock Unit Award AgreementGlobal Restricted Stock Unit Award Agreement • February 14th, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledFebruary 14th, 2022 Company Industry JurisdictionTHIS AGREEMENT, including any appendix for the Participant’s country (the “Non-U.S. Countries Additional Terms Appendix”), the appendix containing additional defined terms related to a change in control (the “Additional Defined Terms Appendix” and, together with the Non-U.S. Countries Additional Terms Appendix, the “Appendices”) and the Participant Restricted Stock Unit Statement attached to the front of this agreement (the “Statement”) sets forth the terms and conditions of the restricted stock unit (the “RSU”) granted by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Company’s Long-Term Stock Incentive Compensation Program (the “Program”). This agreement, the Appendices and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”
Amended and Restated Employment Agreement for Michael A. Mussallem Edwards Lifesciences Corporation March 30, 2009Employment Agreement • May 8th, 2009 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledMay 8th, 2009 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the "Restated Agreement") is made, entered into, and is effective as of the 30th day of March 2009 (the "Effective Date"), by and between Edwards Lifesciences Corporation, a Delaware corporation (the "Company"), and Michael A. Mussallem (the "Executive").
FIVE YEAR CREDIT AGREEMENT dated as of July 15, 2022 among EDWARDS LIFESCIENCES CORPORATION, as a Borrower CERTAIN SUBSIDIARIES, as Borrowers BANK OF AMERICA, N.A., as Administrative Agent JPMORGAN CHASE BANK, N.A., as Syndication Agent MORGAN STANLEY...Five Year Credit Agreement • July 21st, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledJuly 21st, 2022 Company Industry JurisdictionFIVE YEAR CREDIT AGREEMENT dated as of July 15, 2022, among EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation (the “Company”); the other US BORROWERS (as defined herein); the SWISS BORROWERS (as defined herein); the JAPANESE BORROWERS (as defined herein); the SINGAPORE BORROWERS (as defined herein); the ADDITIONAL FOREIGN BORROWERS (as defined herein) (the Company, the other US Borrowers, the Swiss Borrowers, the Japanese Borrowers, the Singapore Borrowers and the Additional Foreign Borrowers being collectively called the “Borrowers”); the LENDERS from time to time party hereto; and BANK OF AMERICA, N.A., as Administrative Agent.
Edwards Lifesciences Corporation Restricted Stock AgreementRestricted Stock Agreement • February 14th, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies
Contract Type FiledFebruary 14th, 2022 Company IndustryYou have been selected to be a Participant in the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program (the “Program”), as specified below:
Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program Global Nonqualified Stock Option Award AgreementGlobal Nonqualified Stock Option Award Agreement • February 14th, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
Contract Type FiledFebruary 14th, 2022 Company Industry JurisdictionTHIS AGREEMENT, including any appendix for the Participant’s country (the “Non-U.S. Countries Additional Terms Appendix”), the appendix containing additional defined terms (the “Additional Defined Terms Appendix” and, together with the Non-U.S. Countries Additional Terms Appendix, the “Appendices”) and the Participant Stock Option Statement attached to the front of this agreement (the “Statement”), sets forth the terms and conditions of the nonqualified stock option (the “Option”) granted by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Company’s Long-Term Stock Incentive Compensation Program (the “Program”). This agreement, the Appendices and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”
WITNESSETH:Tokumei Kumiai Agreement • April 5th, 2000 • Edwards Lifesciences Corp • Services-commercial physical & biological research
Contract Type FiledApril 5th, 2000 Company Industry
Restricted Stock Units AgreementRestricted Stock Units Agreement • February 14th, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies
Contract Type FiledFebruary 14th, 2022 Company IndustryTHIS AGREEMENT, effective as of the Date of Grant set forth above, represents the grant of Restricted Stock Units by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named above, pursuant to the provisions of the Program.
Form of [Amended and Restated] Change-in-Control Severance Agreement Dated [ ] by and between EDWARDS LIFESCIENCES CORPORATION andChange-in-Control Severance Agreement • November 7th, 2012 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • California
Contract Type FiledNovember 7th, 2012 Company Industry JurisdictionTHIS [AMENDED AND RESTATED] CHANGE-IN-CONTROL SEVERANCE AGREEMENT (this “Agreement”) is made, entered into, and is effective as of [ ] (hereinafter referred to as the “Effective Date”), by and between EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation (the “Company”), and [ ] (the “Executive”).
Change-in-Control Severance Agreement between Edwards Lifesciences Corporation and Effective July 10, 2008Change-in-Control Severance Agreement • March 2nd, 2009 • Alliance HealthCare Services, Inc. • Orthopedic, prosthetic & surgical appliances & supplies
Contract Type FiledMarch 2nd, 2009 Company IndustryTHIS CHANGE-IN-CONTROL SEVERANCE AGREEMENT is made effective as of the day of (hereinafter referred to as the "Effective Date"), by and between Edwards Lifesciences Corporation (the "Company"), a Delaware corporation, and (the "Executive").
SECOND AMENDMENT AND RESTATEMENT AGREEMENT dated as of March 27, 2003 among EDWARDS LIFESCIENCES CORPORATION as Borrower The Lenders Party Hereto JPMORGAN CHASE BANK as Administrative Agent CREDIT SUISSE FIRST BOSTON, CAYMAN ISLANDS BRANCH AND...364-Day Credit Agreement • May 15th, 2003 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
Contract Type FiledMay 15th, 2003 Company Industry JurisdictionSECOND AMENDMENT AND RESTATEMENT AGREEMENT dated as of March 27, 2003 (this "Amendment and Restatement"), in respect of the 364-DAY CREDIT AGREEMENT dated as of March 30, 2000, as amended through the date hereof (the "Existing Credit Agreement"), among EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation (the "Company"); the LENDERS from time to time party hereto; JPMORGAN CHASE BANK, as Administrative Agent; CREDIT SUISSE FIRST BOSTON, CAYMAN ISLANDS BRANCH AND WACHOVIA BANK, N.A., as Co-Syndication Agents and THE BANK OF NOVA SCOTIA AND BANK OF AMERICA, N.A., as Co-Documentation Agents.
AMENDMENT AND RESTATEMENT AGREEMENT dated as of March 28, 2002 among EDWARDS LIFESCIENCES CORPORATION as Borrower The Lenders Party Hereto JPMORGAN CHASE BANK as Administrative Agent CREDIT SUISSE FIRST BOSTON, CAYMAN ISLANDS BRANCH AND WACHOVIA BANK,...364-Day Credit Agreement • May 13th, 2002 • Edwards Lifesciences Corp • Services-commercial physical & biological research • New York
Contract Type FiledMay 13th, 2002 Company Industry JurisdictionAMENDMENT AND RESTATEMENT AGREEMENT dated as of March 28, 2002 (this "Amendment and Restatement"), in respect of the 364-DAY CREDIT AGREEMENT dated as of March 30, 2000, as amended and restated as of March 29, 2001 (the "Existing Credit Agreement"), among EDWARDS LIFESCIENCES CORPORATION, a Delaware corporation (the "Company"); the LENDERS from time to time party hereto; JPMORGAN CHASE BANK, as Administrative Agent; CREDIT SUISSE FIRST BOSTON, CAYMAN ISLANDS BRANCH AND WACHOVIA BANK, N.A., as Co-Syndication Agents and THE BANK OF NOVA SCOTIA AND BANK OF AMERICA, N.A., as Co-Documentation Agents.
MASTER AGREEMENTMaster Agreement • June 6th, 2005 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • California
Contract Type FiledJune 6th, 2005 Company Industry JurisdictionThis MASTER AGREEMENT (this “Agreement”) is made and entered into as of this 2nd day of June, 2005, by and between Edwards Lifesciences PVT, Inc., a Delaware corporation (“Edwards”), and 3F Therapeutics, Inc., a Delaware corporation (“3F Therapeutics” and, together with Edwards, are each referred to herein as a “Party” and collectively as the “Parties”).